TIM-3/Gal-9 signaling is the molecular target for human myeloid leukemia treatment
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-10-01
|
Series: | Hematology, Transfusion and Cell Therapy |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2531137920301334 |